scholarly journals Rectal plasmablastic lymphoma in Ebstein Barr virus positive and human immunodeficiency virus negative subject after external radiation therapy for prostatic cancer

2021 ◽  
Vol 84 (4) ◽  
pp. 659-661
Author(s):  
L Bricman ◽  
P Yengue ◽  
C Miscu ◽  
S Junius ◽  
F Waignein ◽  
...  

Plasmablastic lymphoma (PBL) represents a rare and aggressive subtype of diffuse large B cells lymphoma (DLBCL) most associated with the human immunodeficiency virus (HIV). Prognosis remains poor despite various treatment approaches. We describe an evolution at six months of HIV negative PBL and Ebstein Barr virus (EBV) positive PBL with chemotherapy. Role of radiotherapy is still unclear.

2013 ◽  
Vol 2013 ◽  
pp. 1-6 ◽  
Author(s):  
Ing Soo Tiong ◽  
Magreet Strauss ◽  
Michael B. Y. Lau ◽  
Shingirai Chiruka

We report a case of Epstein-Barr-virus-(EBV-) positive primary cutaneous plasmablastic lymphoma in a human-immunodeficiency-virus-(HIV-) negative, immunocompetent 62-year-old female patient. We postulate that her lymphoma development is due to the longstanding use of pyrimethamine for essential thrombocythemia. This has never been described in the literature.


2011 ◽  
Vol 35 (12) ◽  
pp. 1571-1577 ◽  
Author(s):  
Jane Jijun Liu ◽  
Ling Zhang ◽  
Ernesto Ayala ◽  
Teresa Field ◽  
Jose L. Ochoa-Bayona ◽  
...  

2021 ◽  
Author(s):  
Tomoyuki Otani ◽  
Kosuke Murakami ◽  
Masatomo Kimura ◽  
Mitsuru Matsuki ◽  
Takao Satou ◽  
...  

Abstract Background Plasmablastic lymphoma is a mature B-cell neoplasm with plasmablastic differentiation, often associated with human immunodeficiency virus (HIV) infection and other forms of immunosuppression. Although it is usually an aggressive disease, spontaneous regression has been seen in a few cases. Plasmablastic lymphoma in the uterus is rare. Here we report a case of atypical lymphoplasmacytic proliferation resembling plasmablastic lymphoma associated with pyometra that disappeared completely as the pyometra resolved. Case presentation A 76-year-old HIV-negative woman presented with abnormal vaginal bleeding. Ultrasound and MRI findings were consistent with pyometra diagnosis. Endometrial biopsy revealed large plasmablastoid cells with abundant cytoplasms and prominent nucleoli proliferating in the endometrium. Immunohistochemistry showed that large cells stained positive for CD138, CD79a, and MUM1, and negative for CD20, PAX5, CD3, and CD5. Ki67 labelled at least 80% of the large cells. Epstein–Barr virus was detected in a small number of cells. The histological picture was highly indicative of lymphoma, especially plasmablastic lymphoma, though the clinical context was unusual. As the pyometra was treated and resolved, the intrauterine abnormality disappeared completely. The patient has been well after 16 months with no sign of recurrent disease. Conclusions This case underscores the sometimes blurry distinction between benign inflammation and lymphomas.


1993 ◽  
Vol 10 (1-2) ◽  
pp. 17-23 ◽  
Author(s):  
M. J. Boyle ◽  
T. B. Sculley ◽  
R. Penny ◽  
W. A. Sewell ◽  
M. Tschuchnigg ◽  
...  

2017 ◽  
Vol 3 (2) ◽  
pp. 20160124
Author(s):  
Jae Pil Hwang ◽  
Soo-Ho Jeong ◽  
Hee Kyung Kim ◽  
Jung Mi Park

2019 ◽  
Vol 2019 ◽  
pp. 1-4
Author(s):  
Alaina J. Kessler ◽  
Bridget K. Marcellino ◽  
Scot A. Niglio ◽  
Bruce E. Petersen ◽  
Adriana K. Malone

Plasmablastic lymphoma (PBL) and plasmablastic plasma cell myeloma (PCM) have many overlapping characteristics. Clinical correlation can help make the distinction between the two entities. Human immunodeficiency virus- (HIV-) negative PBL is a rare disease, making the diagnosis more challenging. While there is no standard of care for PBL, current recommendations include dose-adjusted EPOCH (etoposide, vincristine, doxorubicin, cyclophosphamide, and prednisone), with or without bortezomib. We report an aggressive case of HIV-negative plasmablastic lymphoma and discuss the challenge in establishing a diagnosis. We review the literature regarding this disease and current recommendations for treatment.


Sign in / Sign up

Export Citation Format

Share Document